GENE ONLINE|News &
Opinion
Blog

Boehringer Ingelheim
Boehringer, Kinoxis Ink $181 Million Pact To Target Oxytocin Receptors
2023-05-08
Boehringer to Leverage RetinAI’s AI Tech to Further Geographic Atrophy Research
2023-04-23
JPM23: Partnerships Take off From JP Morgan Healthcare Conference 2023 Day One
2023-01-10
Eli Lilly and BI Notch Clinical Win for Kidney Disease Drug
2022-11-07
Boehringer Ingelheim, Evotec and bioMérieux Form $40M Venture to Combat Antimicrobial Resistance
2022-07-07
Eli Lilly and Boehringer Ingelheim’s Jardiance Shows Encouraging Phase 3 HFpEF Data
2021-07-07
Boehringer Ingelheim’s Newest Acquisition Reinforces its Focus on Immuno-Oncology
2020-12-14
The Evolution of Lung Cancer Therapies at a Glance
2020-04-16
Boehringer Ingelheim’s Ofev Becomes First FDA Approved Treatment for Progressive Interstitial Lung Diseases
2020-03-11
Boehringer Ingelheim’s New Drug – Nintedanib – Lowers Pulmonary Fibrosis by 57%
2019-10-21
Weekly in Asia 2019|JULY
2019-07-11
LATEST
Ginkgo Bioworks and Pfizer Forge $331 Million Collaboration for RNA-Based Drug Discovery
2023-09-29
Johnson & Johnson Partners with Singapore to Boost Life Sciences Innovation
2023-09-28
Vietnam and South Korea Strengthen Cooperation in Multiple Sectors
2023-09-27
PeptiDream and Genentech Collaborate on Novel Peptide-Radioisotope Drug Conjugates
2023-09-27
AcuraStem and Takeda Collaborate on Innovative ALS Treatment
2023-09-27
Seven AI/ML for Life Sciences Companies Identified as Innovators in New Clarivate Companies to Watch Report
2023-09-27
GeneOnline’s Weekly News Highlights: Sept 17-Sept 22
2023-09-26
EVENT
2023-10-04
BioFuture 2023
New York city,USA
Scroll to Top